MAGNOVA is an Indian brand of cefepime + tazobactam 1000+125 mg, manufactured by Lupin. A reserve drug for serious hospital infections, including Pseudomonas.
Cefepime, a fourth-generation cephalosporin, destroys the cell wall of gram-positive and gram-negative bacteria. Tazobactam blocks extended-spectrum beta-lactamases (ESBL) that resistant bacteria use to destroy antibiotics.
Whether to use it, the dose and the length of treatment are decided by your hospital doctor.
Sacred Leaves exports MAGNOVA directly from New Delhi, India, with no intermediaries. Since 2015 we have completed more than 101,000 shipments to patients, clinics, pharmacies and distributors around the world.
Delivery times depend on the destination country and its customs. Before ordering, please make sure the medicine is allowed to be imported into your country. Full details: Delivery and payment.
Bank transfer (SWIFT) or PayPal. Customers in Russia can also pay in rubles via Sber QR code. Your order is dispatched once payment is received.
Do I need a prescription for MAGNOVA?
Yes. It is a prescription medicine, prescribed and monitored by your hospital doctor; use it only as directed. Please also check your country's rules on importing medicines for personal use before ordering.
How do I take cefepime + tazobactam?
Given IV in hospital, usually every 8–12 hours; the doctor sets the dose by severity and kidney function.
Can it be given at home?
Injectable antibiotics are normally given in hospital or a treatment room: the doctor sets the dose by weight, kidney function and severity of infection, and staff monitor the reaction.
How long does delivery take?
By international post, usually 10–20 days; by air freight, 7–10 days. Exact timing depends on your country and its customs. You receive a tracking number once the parcel is dispatched.
Can I buy MAGNOVA wholesale?
Yes. We supply distributors, pharmacies, hospitals and clinics worldwide. Use the wholesale request form on this page or message us on WhatsApp.
Treatment of severe infections caused by susceptible microorganisms, including pneumonia, urinary tract infections, skin infections, intra-abdominal infections, and sepsis.
Administered intravenously or intramuscularly after reconstitution of the powder. Dosage and frequency are determined by the physician based on infection severity and renal function.
Contraindications
Side effects









